Intranasal Dexmedetomidine Sedation for Pediatric CT Imaging

NCT01900405 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-07-16

No results posted yet for this study

Summary

This study has the objective to determine if intranasal dexmedetomidine, a sedative, is suitable for pediatric sedation in children undergoing tomographic scans.

Conditions

Interventions

DRUG

Dexmedetomidine

Sponsors & Collaborators

Principal Investigators

  • Keira Mason, MD · Boston Children's Hospital, Harvard Medical School

Eligibility

Min Age
1 Month
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01900405 on ClinicalTrials.gov